Neonatal paroxetine withdrawal syndrome.
Four term neonates presented with symptoms such as jitteriness and necrotising enterocolitis after paroxetine exposure in utero.
Stiskal
J A
JA
Division of Neonatology, Morristown Memorial Hospital, Morristown, New Jersey, USA.
Kulin
N
N
Koren
G
G
Ho
T
T
Ito
S
S
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D004357:Drug Synergism; D020345:Enterocolitis, Necrotizing / Q000209:etiology; D005260:Female; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D009357:Neonatal Abstinence Syndrome / Q000209:etiology*; D017374:Paroxetine / Q000009:adverse effects*; D017366:Serotonin Receptor Agonists / Q000494:pharmacology; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*
D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D006634:Histamine H1 Antagonists; D017374:Paroxetine; D017366:Serotonin Receptor Agonists; D017367:Selective Serotonin Reuptake Inhibitors